systemic scleroderma: A chronic disorder, possibly autoimmune, marked by excessive production of collagen which results in hardening and thickening of body tissues. The two types of systemic scleroderma, limited cutaneous and diffuse cutaneous are classified with focus on the extent of affected skin. A relationship exists between the extent of skin area affected and degree of internal organ/system involvement. Systemic scleroderma can manifest itself in pulmonary fibrosis, Raynaud's syndrome, digestive system telangiectasias, renal hypertension and/or pulmonary hypertension.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
881 |
4. Check minimum number of eventsNone |
881 |
5. Include endpointsNone |
881 |
6. Filter based on genotype QC (FinnGen only) |
881 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M30-M36
- Name in latin
- Sclerosis systemica
Similar endpoints
↥List of similar endpoints to
Systemic sclerosis
based on the number of shared cases.
Similar with more cases:
- Systemic sclerosis (FG)
- Systemic connective tissue disorders
- Finngen Rheumatological endpoints
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4561 | 3620 | 887 |
| Only index persons | 3885 | 3150 | 735 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.10 | 0.02 |
| Only index persons | 0.10 | 0.12 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 56.25 | 56.54 | 55.13 |
| Only index persons | 55.13 | 55.34 | 54.21 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 881 | 728 | 153 |
| Unadjusted period prevalence (%) | 0.22 | 0.25 | 0.07 |
| Median age at first event (years) | 54.75 | 54.51 | 55.91 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 793
- Matched controls
- 7929
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
323.0
481
*
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
+∞
323.0
349
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
27.5
316.8
483
424
P01BA02
ATC
hydroxychloroquine; oral
27.7
286.9
424
316
C08CA05
ATC
nifedipine; systemic
25.8
233.5
344
228
I73.0
ICD-10 Finland
Raynaud syndrome
56.4
172.2
203
48
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
13.1
158.2
309
368
M34.0
ICD-10 Finland
Progressive systemic sclerosis
+∞
156.6
145
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
1746.0
152.2
143
*
XX9XE
NOMESCO Finland
Other ultrasound examination
67.7
122.4
140
25
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
11.6
108.0
217
250
XPX04
NOMESCO Finland
Angioscopy
225.7
97.8
99
5
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
131.2
97.6
103
9
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
+∞
93.6
88
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
8.7
91.8
218
330
L04AA06
ATC
mycophenolic acid; systemic
44.1
84.2
104
27
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
78.2
495
2256
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
12.5
77.2
145
139
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.1
70.9
392
1535
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.6
68.9
300
932
L04AX01
ATC
azathioprine; systemic
10.9
66.7
134
145
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
669.3
63.8
62
*
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
62.3
59
*
XG410
NOMESCO Finland
Flow-volume spirometry
11.7
61.7
119
118
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
7.9
57.6
141
212
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
82.6
54.8
61
8
H02AB06
ATC
prednisolone; systemic
3.3
54.2
493
2658
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
13.5
53.3
95
79
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
13.9
51.8
91
73
L88
ICPC
Rheumatoid/seropositive arthritis
8.8
48.6
109
141
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
94.6
48.5
53
6
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.9
47.1
142
281
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
462.4
44.7
44
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
24.0
39.3
56
25
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
38.3
384
2027
NH3EA
NOMESCO Finland
Feet X-ray examination with load
12.5
36.7
67
58
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
4.2
36.3
151
416
G04BE03
ATC
sildenafil; oral
37.5
36.3
46
13
C08CA02
ATC
felodipine; oral
4.6
34.7
130
323
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.3
33.9
198
721
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.6
33.2
124
306
M34
ICD-10 Finland
Systemic sclerosis
340.5
33.1
33
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.3
32.0
130
348
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
15.8
31.8
52
35
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
9.0
30.6
66
79
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.7
29.6
89
172
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
+∞
29.3
28
*
C02KX01
ATC
bosentan; oral
302.5
29.0
29
*
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
10.2
28.4
57
60
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
6.0
27.8
80
146
TGC00
NOMESCO Finland
Bronchial lavation
10.4
26.3
52
53
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.9
26.1
114
324
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
14.0
25.8
44
33
R06.0
ICD-10 Finland
Dyspnoea
2.5
25.7
249
1221
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.6
25.2
126
400
R4120
NOMESCO Finland
Occupational therapy
4.5
25.2
93
225
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
40.3
25.0
31
8
E0000UV
ATC
NA
2.2
24.3
375
2293
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
8.9
24.2
52
62
SBA10
NOMESCO Finland
Measurement of excretion of saliva
23.6
24.1
34
15
L04AD01
ATC
ciclosporin; systemic
9.4
23.6
49
55
7101A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic sclerosis[SCLERODERMA]
+∞
23.0
22
*
C08CA01
ATC
amlodipine; oral
2.2
22.9
314
1804
K74.3
ICD-10 Finland
Primary biliary cirrhosis
18.6
22.3
34
19
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
22.1
221
1084
J01FF01
ATC
clindamycin; systemic
2.3
21.7
257
1369
WZA10
NOMESCO Finland
Long statement of health and health related matters
12.4
21.7
39
33
H04.10
ICD-10 Finland
Dry eye syndrome
3.0
20.7
129
477
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
20.6
402
2651
L04AA01
ATC
[U] ciclosporin; systemic
12.1
20.4
37
32
RT172
NOMESCO Finland
NA
+∞
19.9
19
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
6.8
19.6
50
78
A02BC02
ATC
pantoprazole; systemic
2.0
19.1
550
4178
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
19.0
195
962
RT160
NOMESCO Finland
NA
+∞
18.8
18
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.6
17.9
83
246
H02AB07
ATC
prednisone; oral
2.6
17.9
146
636
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
17.8
17
*
G73.7*M34.8
ICD-10 Finland
Myopathy in scleroderma
+∞
17.8
17
*
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
17.4
17.5
27
16
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
17.3
182
902
M01CC01
ATC
penicillamine; oral
51.2
17.0
20
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
17.0
354
2336
GD1AD
NOMESCO Finland
Thorax CT examination
4.7
16.8
58
131
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
+∞
16.7
16
*
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
+∞
16.7
16
*
C02KX04
ATC
macitentan; oral
173.5
16.6
17
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
12.5
16.4
29
24
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.3
16.3
84
271
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
6.6
16.3
42
67
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.5
16.3
78
238
A02BC01
ATC
omeprazole; systemic
2.0
16.2
248
1446
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.7
16.0
72
209
RT274
NOMESCO Finland
NA
+∞
15.7
15
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.9
14.8
94
350
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.8
14.5
96
368
A05AA02
ATC
ursodeoxycholic acid; oral
6.5
14.4
37
59
R13
ICD-10 Finland
Dysphagia
3.4
14.3
72
229
J01MA12
ATC
levofloxacin; systemic
2.2
14.1
155
778
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
4.5
14.0
50
118
I27.0
ICD-10 Finland
Primary pulmonary hypertension
30.6
13.9
18
6
RT272
NOMESCO Finland
NA
24.3
13.8
19
8
UJF32
NOMESCO Finland
Coloscopy
1.9
13.8
231
1381
C03CA01
ATC
furosemide; systemic
2.0
13.8
210
1211
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
13.6
13
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
13.6
13
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.9
335
2316
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
50.9
12.9
15
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.7
12.7
43
96
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
12.5
12.7
22
18
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
12.5
12
*
L99
ICPC
Musculoskeletal disease other
5.7
12.4
35
64
M05BA04
ATC
alendronic acid; oral
2.6
12.3
94
392
M05BX04
ATC
denosumab; parenteral
3.3
12.3
62
198
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
12.0
86
346
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
12.0
120
575
E000001
ATC
NA
2.0
11.8
185
1068
RT271
NOMESCO Finland
NA
30.5
11.7
15
5
ZX120
NOMESCO Finland
Intravenous
2.5
11.5
92
393
R15
ICD-10 Finland
Faecal incontinence
4.4
11.5
41
97
RT231
NOMESCO Finland
NA
+∞
11.5
11
*
73409
ICD-8 Finland
Diffuse diseases of connective tissue, Sclerosis systematica NUD
+∞
11.5
11
*
J01DB01
ATC
cefalexin; oral
1.9
11.4
651
5618
D06BX01
ATC
metronidazole; topical
2.3
11.3
113
538
S18
ICPC
Laceration/cut
1.7
11.2
328
2318
A02BC05
ATC
esomeprazole; systemic
1.7
11.2
347
2500
R50.9
ICD-10 Finland
Fever, unspecified
2.3
11.1
112
537
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.6
11.1
50
146
M25.5
ICD-10 Finland
Pain in joint
1.8
11.1
249
1621
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
11.1
114
553
N03AX16
ATC
pregabalin; oral
1.9
11.0
201
1226
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
10.9
76
300
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
43.9
10.9
13
*
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
5.4
10.7
31
59
A02BC03
ATC
lansoprazole; oral
1.8
10.6
246
1619
R4190
NOMESCO Finland
Nutritional therapy
4.3
10.6
38
91
K62.3
ICD-10 Finland
Rectal prolapse
6.7
10.6
26
40
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
+∞
10.4
10
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
10.4
237
1548
K22.7
ICD-10 Finland
Barrett oesophagus
8.3
10.4
22
27
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.4
10.3
36
84
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.0
10.2
40
104
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
10.2
309
2189
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
8.6
10.1
21
25
SPAT1263
SPAT
Sampling
1.6
10.1
343
2510
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.4
10.1
29
55
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.9
10.0
32
68
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.7
10.0
28
51
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
10.0
69
269
M05BA07
ATC
risedronic acid; oral
3.3
9.8
48
151
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.2
9.8
51
168
NHQ40
NOMESCO Finland
Amputation of toe
6.9
9.7
23
34
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.6
9.5
70
284
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
6.3
9.4
24
39
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
9.4
9
*
M34.2
ICD-10 Finland
Systemic sclerosis induced by drugs and chemicals
+∞
9.4
9
*
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
9.4
9
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
9.2
93
447
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.1
9.2
49
164
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.6
9.2
68
278
C02DE02
ATC
NA
6.8
9.2
22
33
M13.9
ICD-10 Finland
Arthritis, unspecified
2.6
9.1
65
261
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
10.2
9.1
17
17
XG466
NOMESCO Finland
Sleep oxymetry
4.0
9.0
35
91
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.4
9.0
43
133
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
9.0
91
437
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
9.0
93
451
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
8.9
206
1340
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
8.9
67
278
TEA00
NOMESCO Finland
Biopsy of lip
9.6
8.8
17
18
K22.1
ICD-10 Finland
Ulcer of oesophagus
5.7
8.8
24
43
J01MA14
ATC
moxifloxacin; systemic
2.3
8.8
78
353
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
8.7
136
779
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
8.6
142
828
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
8.6
91
446
EBA10
NOMESCO Finland
Surgical removal of tooth
2.2
8.6
86
410
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
11.7
8.6
15
13
J02AC01
ATC
fluconazole; systemic
1.6
8.6
364
2784
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.2
8.5
90
441
RT310
NOMESCO Finland
NA
27.8
8.5
11
*
RJ420
NOMESCO Finland
NA
27.8
8.5
11
*
M33.2
ICD-10 Finland
Polymyositis
91.0
8.4
9
*
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
91.0
8.4
9
*
GX1K5
NOMESCO Finland
Diffusion capacity
91.0
8.4
9
*
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
6.3
8.4
21
34
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.5
8.3
28
64
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.0
8.3
116
636
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.9
8.2
48
171
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.3
8.2
40
126
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
8.2
104
548
S97
ICPC
Chronic ulcer skin
2.9
8.1
48
173
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.2
8.1
41
133
H03AA01
ATC
levothyroxine sodium; systemic
1.7
8.1
214
1442
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
9.0
8.1
16
18
A07AA02
ATC
nystatin; oral
2.5
8.0
61
255
J01AA04
ATC
lymecycline; systemic
2.0
8.0
105
565
J01DA01
ATC
[U] cefalexin; systemic
1.5
8.0
484
3996
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.0
7.9
43
147
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
10.9
7.8
14
13
D07AC01
ATC
betamethasone; topical
1.6
7.8
261
1869
J01FA06
ATC
roxithromycin; oral
1.5
7.8
320
2412
NF1AA
NOMESCO Finland
Hip X-ray examination
2.2
7.8
76
361
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
15.2
7.7
12
8
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
45.4
7.7
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
7.7
75
354
SFA00
NOMESCO Finland
Small filling
2.0
7.7
106
579
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
7.6
60
256
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.1
7.6
82
406
NDQ20
NOMESCO Finland
Amputation of finger
12.0
7.6
13
11
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
7.6
310
2329
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
25.3
7.6
10
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
7.5
143
874
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
7.5
254
1819
I73.1
ICD-10 Finland
Thromboangiitis obliterans [Buerger]
80.8
7.4
8
*
M35
ICD-10 Finland
Other systemic involvement of connective tissue
80.8
7.4
8
*
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
7.7
7.4
16
21
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
7.4
120
696
L95
ICPC
Osteoporosis
3.0
7.4
42
147
A03FA02
ATC
cisapride; oral, rectal
2.2
7.3
71
336
C08DB01
ATC
diltiazem; oral
2.9
7.3
42
148
M43.9
ICD-10 Finland
Deforming dorsopathy, unspecified
+∞
7.3
7
*
L94.3
ICD-10 Finland
Sclerodactyly
+∞
7.3
7
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
7.3
7
*
M32
ICD-10 Finland
Systemic lupus erythematosus
+∞
7.3
7
*
286
Kela drug reimbursment
Ciclosporin eye drop
+∞
7.3
7
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
7.3
7
*
73401
ICD-8 Finland
Diffuse diseases of connective tissue, Sclerosis systematica acrosclerotica
+∞
7.3
7
*
SPAT1254
SPAT
Administration of medicine
1.9
7.2
112
640
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.0
7.1
38
129
NDL52
NOMESCO Finland
Tenosynovectomy of hand
8.0
7.1
15
19
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
6.1
7.1
18
30
L12
ICPC
Hand/finger symptom/complaint
1.8
7.0
117
685
E000003
ATC
NA
2.8
7.0
44
164
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
6.9
118
692
WX110
NOMESCO Finland
Local anesthesy
1.5
6.9
527
4504
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
6.9
535
4588
R4180
NOMESCO Finland
Podiatric therapy
6.8
6.8
16
24
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
6.8
6.8
16
24
S09
ICPC
Infected finger/toe
3.4
6.8
31
94
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
11.1
6.8
12
11
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
11.1
6.8
12
11
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
6.8
397
3203
ADA20
NOMESCO Finland
Thoracal sympathectomy
40.4
6.8
8
*
NGQ20
NOMESCO Finland
Amputation of lower leg
16.9
6.8
10
6
R1250
NOMESCO Finland
Evaluation of functional capability
4.0
6.7
25
64
WX002
NOMESCO Finland
Sedation and analgesia
1.7
6.7
154
993
J96.1
ICD-10 Finland
Chronic respiratory failure
5.0
6.7
20
41
RT171
NOMESCO Finland
NA
22.7
6.7
9
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.4
6.7
53
227
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
6.6
232
1668
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
12.4
6.6
11
9
R76.0
ICD-10 Finland
Raised antibody titre
12.4
6.6
11
9
M35.7
ICD-10 Finland
Hypermobility syndrome
12.4
6.6
11
9
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
6.6
72
358
RF210
NOMESCO Finland
NA
3.5
6.6
28
81
K59.09
ICD-10 Finland
Constipation, unspecified
2.5
6.6
47
192
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.3
6.6
60
275
JGC01
NOMESCO Finland
Laparoscopic rectopexy
6.9
6.5
15
22
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
6.5
143
909
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.3
6.5
58
265
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
6.5
43
168
C03DA01
ATC
spironolactone; oral
2.0
6.4
78
407
A01AB09
ATC
miconazole; local oral
2.0
6.4
78
407
GX1D5
NOMESCO Finland
Flow volume spirometry
70.4
6.4
7
*
Z94.2
ICD-10 Finland
Lung transplant status
70.4
6.4
7
*
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
70.4
6.4
7
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
6.4
184
1259
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.4
6.4
29
88
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.5
6.4
48
199
M45
ICD-10 Finland
Ankylosing spondylitis
4.5
6.4
21
48
Z01.9
ICD-10 Finland
Special examination, unspecified
2.4
6.4
49
208
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
6.4
134
840
E000007
ATC
NA
2.4
6.4
52
228
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.3
668
6075
NDQ48
NOMESCO Finland
Revision or amputation or exarticulation of finger
18.2
6.3
9
5
B01AC27
ATC
selexipag; oral
+∞
6.3
6
*
XQ844
NOMESCO Finland
Other microscope or electron microscope examination
+∞
6.3
6
*
I27.1
ICD-10 Finland
Kyphoscoliotic heart disease
+∞
6.3
6
*
RJ126
NOMESCO Finland
NA
+∞
6.3
6
*
383
Kela drug reimbursment
Selexipag
+∞
6.3
6
*
K76.9
ICD-10 Finland
Liver disease, unspecified
4.8
6.3
19
40
NH3AE
NOMESCO Finland
Feet ultrasound examination
26.9
6.2
8
*
SPAT1325
SPAT
Vaccination
1.5
6.2
253
1880
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
5.1
6.2
18
36
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.2
6.2
30
96
K11.2
ICD-10 Finland
Sialoadenitis
3.0
6.1
32
108
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.8
6.1
116
704
N02AA05
ATC
oxycodone; systemic
1.8
6.1
101
587
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
6.1
60
287
GD1UN
NOMESCO Finland
Lung circulation SPECT
8.7
6.1
12
14
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
10.1
6.0
11
11
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
270
184
20.72
317.95
2.3
1.1
g/l
0.2
0.2
7.28
258
174
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
270
194
19.63
309.00
2.3
1.1
g/l
1.1
1.2
8.50
258
181
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
298
139
31.89
307.65
1.6
1.1
u/ml
36.6
26.2
0.31
50
11
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
365
167
36.61
307.65
1.6
1.1
u/ml
2.9
2.7
—
92
10
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
344
122
45.62
307.65
1.5
1.1
u/ml
34.1
16.2
—
52
5
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
370
185
33.76
307.65
1.6
1.1
u/ml
9.5
21.9
—
24
8
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
311
209
22.45
307.65
2.5
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
267
128
29.50
307.65
1.5
1.1
u/ml
0.4
—
—
9
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
365
171
35.74
307.65
1.7
1.1
u/ml
7.7
3.9
0.80
132
18
(3015171) Extractable nuclear Ab [Units/volume] in Serum
296
262
16.51
301.02
1.7
1.1
u/ml
7.2
0.7
4.01
24
17
(3037522) Nuclear Ab [Titer] in Serum
505
961
10.97
292.68
1.9
1.3
titre
1861.8
387.3
39.52
339
196
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
607
1995
7.57
190.50
4.7
2.9
ng/l
674.1
1013.9
3.19
567
1668
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
114
45
28.95
166.35
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
114
45
28.95
166.35
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
114
45
28.95
166.35
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
114
46
28.32
165.04
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
114
46
28.32
165.04
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
114
46
28.32
165.04
1.4
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
776
3638
10.51
154.62
13.5
5.3
e9/l
0.6
0.6
0.48
752
3125
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
90
20
50.01
154.22
2.5
1.2
ug/l
8.5
8.8
0.11
90
20
(3006315) Basophils [#/volume] in Blood
777
3660
10.51
153.60
13.7
5.3
e9/l
0.0
0.0
1.01
753
3144
(3013115) Eosinophils [#/volume] in Blood
781
3789
10.35
146.50
14.1
5.5
e9/l
0.2
0.2
0.02
760
3313
(3019198) Lymphocytes [#/volume] in Blood
775
3741
9.91
145.83
13.7
5.2
e9/l
1.7
1.9
7.73
753
3288
(42870588) Differential panel, method unspecified - Blood
585
2430
5.19
123.36
12.8
5.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
695
3316
6.19
123.08
13.9
5.4
%
0.8
0.7
4.79
687
3068
(3019069) Monocytes/100 leukocytes in Blood
708
3438
6.39
122.52
14.6
5.6
%
9.0
8.4
6.18
700
3201
(3006504) Eosinophils/100 leukocytes in Blood
705
3418
6.32
122.03
14.0
5.4
%
3.0
2.8
1.34
697
3159
(3018010) Neutrophils/100 leukocytes in Blood
710
3490
6.33
120.02
13.5
5.3
%
58.2
56.8
3.04
700
3244
(3002030) Lymphocytes/100 leukocytes in Blood
712
3525
6.32
118.80
14.1
5.5
%
27.3
28.5
2.71
702
3267
(3013650) Neutrophils [#/volume] in Blood by Automated count
785
4305
8.56
114.03
16.7
8.7
e9/l
3.9
4.0
1.11
759
3758
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
524
2138
4.58
109.28
3.2
2.0
u/l
105.0
198.4
2.37
509
2005
(3005719) IgG [Mass/volume] in Serum or Plasma
230
499
5.88
105.28
3.4
2.8
g/l
10.3
10.1
0.21
214
454
(3004616) Nuclear Ab [Presence] in Serum
98
75
14.58
104.84
1.6
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
235
529
5.69
103.13
4.4
2.9
ng/l
113.1
168.4
1.99
226
481
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
66
23
30.94
99.63
1.2
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
80
49
17.86
96.23
1.4
1.1
u/ml
40.6
—
—
7
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
80
50
17.50
95.26
1.4
1.1
u/ml
22.7
—
—
15
0
(3013293) Extractable nuclear Ab [Presence] in Serum
88
5
195.20
85.89
1.7
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
177
395
5.36
77.04
1.7
1.7
g/l
1.4
1.3
0.58
161
357
(3013707) Erythrocyte sedimentation rate by Westergren method
821
5598
7.85
69.42
11.6
3.8
mm/h
12.5
12.1
0.47
809
5168
(3025159) Blasts/100 leukocytes in Blood
199
540
4.47
67.72
5.7
3.9
%
0.0
0.8
0.59
42
124
(3002179) Metamyelocytes/100 leukocytes in Blood
202
558
4.40
67.11
5.3
3.7
%
0.4
0.7
1.06
40
116
(3035350) Ketones [Presence] in Urine by Test strip
632
3644
3.60
66.15
6.0
3.6
estimate
0.0
0.0
0.00
166
669
(3017181) Myelocytes/100 leukocytes in Blood
211
614
4.20
65.25
5.8
3.7
%
0.7
1.1
0.99
51
172
(3021440) Promyelocytes/100 leukocytes in Blood
203
579
4.26
64.44
5.8
3.8
%
0.1
0.2
0.74
49
154
(40760892) CBC W Ordered Manual Differential panel - Blood
379
1644
3.29
63.48
8.3
4.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
767
5108
4.88
62.67
8.9
4.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
627
3676
3.45
62.14
7.8
4.9
estimate
0.0
0.0
0.50
171
663
(3009261) Glucose [Presence] in Urine by Test strip
630
3710
3.45
61.85
6.0
3.6
estimate
0.0
0.0
0.80
173
650
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
820
5840
6.84
59.10
14.4
7.0
u/l
76.0
78.0
0.53
813
5483
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
38
12
33.05
58.68
1.3
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
38
12
33.05
58.68
1.3
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
38
12
33.05
58.68
1.3
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
38
12
33.05
58.68
1.3
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
394
1829
3.09
57.50
3.6
2.4
umol/l
657.9
6019.2
5.60
357
1584
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
565
3261
3.04
54.57
3.2
2.2
nmol/l
80.8
79.0
0.78
526
2925
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
313
1361
3.02
50.04
1.4
1.3
iu/ml
39.9
34.4
0.22
134
432
(3034770) Mitochondria Ab [Titer] in Serum
94
174
5.93
49.47
1.3
1.2
titre
1019.3
561.3
—
14
8
(3006184) Hemoglobin [Mass/volume] in Capillary blood
85
144
6.43
48.93
2.0
2.1
g/l
122.8
128.7
0.71
27
106
(3021589) Normoblasts [#/volume] in Blood
549
3285
2.78
46.60
18.1
8.7
e9/l
0.0
0.0
0.17
504
2681
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
584
3636
2.80
45.31
8.3
6.2
mmol/l
1.2
1.2
0.87
494
3061
(3007566) Smooth muscle Ab [Titer] in Serum
89
171
5.68
44.94
1.2
1.2
titre
82.2
72.3
—
9
13
(3030905) Polymorphonuclear cells [#/volume] in Blood
78
134
6.29
44.21
3.5
3.0
e9/l
3.9
4.4
1.24
78
134
(3018095) Leukocytes [#/volume] in Urine
450
2486
2.66
44.05
5.1
3.3
e6/l
55.5
89.9
0.82
314
1722
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
539
3286
2.65
42.54
7.5
5.3
mmol/l
1.2
1.2
0.55
500
2966
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
78
140
6.02
42.26
3.6
3.3
%
57.8
59.4
0.46
78
140
(3000492) Spirometry study
195
710
3.24
41.57
2.3
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
310
1459
2.74
41.40
1.6
1.5
g/l
2.3
2.3
0.01
206
853
(3011397) Hemoglobin [Presence] in Urine by Test strip
337
1696
2.60
38.85
5.6
3.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
248
1078
2.81
38.22
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
87
190
4.97
37.93
2.4
2.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
396
2190
2.47
36.87
4.4
3.6
ph
7.4
7.4
2.79
86
412
(4268621)
52
71
7.72
36.38
2.2
2.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
89
209
4.62
35.50
1.5
1.5
titre
193.3
102.2
—
6
9
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
61
104
6.23
34.73
1.4
1.2
u/ml
5.6
4.9
0.06
25
28
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
84
193
4.71
34.40
3.1
2.2
ug/l
118.3
236.0
2.09
78
179
(3007853) Bacteria identified in Skin by Aerobe culture
187
759
2.86
32.27
2.3
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
85
213
4.31
31.15
1.8
1.6
iu/ml
0.1
0.1
0.10
14
38
(3029937) Albumin [Presence] in Urine by Test strip
349
1937
2.33
30.94
7.3
3.9
estimate
0.0
0.0
0.80
173
656
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
42
54
8.12
30.86
2.0
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
57
106
5.68
29.64
1.4
1.2
u/ml
4.2
6.6
0.38
26
39
(3022948) Iron [Moles/volume] in Serum or Plasma
227
1058
2.54
29.52
3.4
2.2
umol/l
11.4
13.3
3.16
218
973
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
263
1313
2.43
29.46
1.3
1.3
u/ml
14.3
11.4
0.24
106
495
(3000850) Epithelial cells [#/volume] in Urine
278
1432
2.38
28.95
3.5
2.3
e6/l
3.9
7.2
4.26
262
1273
(3017143) Hepatitis C virus Ab [Presence] in Serum
171
701
2.79
28.71
1.4
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
338
1904
2.26
28.40
4.1
2.7
e6/l
0.2
0.5
2.68
286
1427
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
199
889
2.60
28.13
3.4
2.3
%
20.3
22.4
1.25
172
763
(36304419) Bacteria [Presence] in Urine
331
1875
2.23
27.18
4.1
2.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
129
469
3.05
26.88
1.7
2.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
316
1769
2.23
26.61
3.5
2.1
mg/l
3.1
3.0
0.10
284
1496
(3020630) Protein [Mass/volume] in Serum or Plasma
142
553
2.87
26.11
1.9
2.8
g/l
65.4
67.0
1.41
131
500
(3011412) CD3 cells [#/volume] in Blood
38
53
7.45
26.03
1.9
2.2
e9/l
1.0
1.1
0.23
25
31
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
22
14
16.09
25.47
1.1
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
204
963
2.46
25.41
3.4
2.2
g/l
2.3
2.4
0.63
194
888
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
59
130
4.79
25.33
1.9
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
440
2842
2.10
25.24
6.7
3.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
347
2063
2.13
24.68
4.2
2.8
e6/l
18.2
86.6
1.36
301
1573
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
227
1150
2.31
23.94
3.0
2.4
e6/l
0.7
1.2
4.48
160
632
(3024561) Albumin [Mass/volume] in Serum or Plasma
469
3144
2.05
23.85
6.2
4.3
g/l
35.4
35.9
1.28
444
2930
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
192
906
2.43
23.80
1.4
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
325
1920
2.10
23.19
11.2
6.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
212
1070
2.29
22.39
2.4
1.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
49
104
4.93
21.97
1.4
1.6
g/l
0.5
0.7
0.79
39
83
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
30
39
7.93
21.78
1.3
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
121
4.60
21.78
1.8
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
200
996
2.30
21.74
2.8
1.9
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
30
40
7.73
21.33
1.9
2.2
%
14.4
13.5
0.07
12
20
(3032080) INR in Blood by Coagulation assay
421
2800
1.96
21.00
9.3
8.1
inr
1.1
1.2
0.63
131
799
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
63
169
3.94
20.98
2.0
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
38
7.86
20.91
1.9
2.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
61
161
4.00
20.77
2.0
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
328
2010
2.01
20.65
5.4
3.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
94
4.99
20.55
1.9
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
148
670
2.45
19.84
2.7
2.0
g/l
0.2
0.2
2.24
136
636
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
50
118
4.43
19.72
12.0
4.5
iu/ml
1649.3
161.8
0.78
16
15
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
534
3914
1.93
19.27
7.7
5.9
umol/l
10.1
10.6
0.65
508
3704
(3028192) IgG subclass 2 [Mass/volume] in Serum
35
62
5.84
19.11
1.2
1.2
g/l
3.0
2.6
0.62
26
46
(3024139) IgG subclass 3 [Mass/volume] in Serum
35
62
5.84
19.11
1.2
1.2
g/l
0.4
0.4
0.53
26
46
(3027135) IgG subclass 1 [Mass/volume] in Serum
35
62
5.84
19.11
1.2
1.2
g/l
8.7
6.9
0.61
26
47
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
246
3.29
19.10
1.9
2.2
g/l
3.1
3.1
0.11
64
196
(3036481) Cortisol [Moles/volume] in Serum or Plasma
146
671
2.41
18.88
1.6
2.1
nmol/l
351.2
381.5
0.70
134
616
(3023368) Bacteria identified in Blood by Culture
293
1775
1.97
18.70
5.0
3.9
—
—
—
0
0
(4062490)
35
64
5.65
18.49
1.2
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
46
107
4.48
18.47
1.6
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
264
3.14
18.20
1.9
2.1
g/l
3.4
3.8
2.14
62
191
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
286
1732
1.96
18.18
1.3
1.3
u/ml
0.5
1.6
2.61
66
457
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
265
3.13
18.09
1.9
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
265
3.13
18.09
1.9
2.1
g/l
7.2
7.4
0.75
65
199
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
47
115
4.26
17.70
1.6
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
152
735
2.29
17.42
2.6
2.5
%
1.9
1.8
0.22
138
667
(3003458) Phosphate [Moles/volume] in Serum or Plasma
168
858
2.18
16.81
5.6
4.7
mmol/l
1.0
1.0
0.22
155
788
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
842
7495
3.79
16.80
27.7
12.6
mg/l
17.2
21.9
5.04
731
5827
(3021879) Hepatitis B virus core Ab [Presence] in Serum
109
462
2.55
16.69
1.3
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
87
329
2.82
16.67
1.3
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
22
9.28
16.48
1.7
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
247
3.09
16.41
2.0
2.2
g/l
10.0
10.2
0.05
65
214
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
47
123
3.98
16.19
2.1
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
147
722
2.24
16.16
3.1
4.4
u/l
255.6
256.5
0.02
142
682
(3034426) Prothrombin time (PT)
20
23
8.87
15.94
1.2
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
113
500
2.45
15.77
2.0
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
23
32
7.35
15.73
1.4
1.2
ratio
1.1
1.1
—
10
12
(3000494) Fungus identified in Specimen by Culture
166
866
2.13
15.66
2.2
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
36
79
4.71
15.52
1.8
1.6
%
54.4
59.3
0.27
21
49
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
39
92
4.39
15.39
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
147
746
2.16
14.83
2.2
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
117
542
2.34
14.71
2.6
2.7
e9/l
71.6
72.7
0.13
94
419
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
15
10.85
14.68
2.4
1.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
18
9.61
14.36
2.4
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
446
3270
1.74
14.30
3.9
2.6
ug/l
105.5
103.9
0.05
415
3026
(3029075) Extractable nuclear Ab panel - Serum
18
21
8.73
14.17
1.3
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
38
94
4.18
14.12
1.3
1.4
u/ml
125.2
115.9
—
7
18
(46235355) HIV 1 and 2 tests - Meaningful Use set
192
1094
1.97
14.10
1.5
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
121
579
2.26
14.08
5.9
3.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
25
43
5.95
14.05
1.2
1.1
titre
127.1
62.9
—
7
7
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
146
754
2.12
14.05
2.2
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
27
51
5.43
13.78
1.8
1.7
%
40.4
38.3
0.07
12
30
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
89
375
2.53
13.75
2.5
2.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
109
504
2.33
13.73
3.7
2.9
e9/l
4.2
4.0
0.34
76
401
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
220
1333
1.87
13.34
4.6
3.7
ng/l
261.7
298.5
0.13
175
987
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
73
283
2.72
13.33
2.0
1.8
g/l
1.5
1.5
0.08
65
247
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
381
2711
1.71
13.31
4.7
3.4
ng/l
24.5
44.1
0.78
268
1778
(3019150) Specific gravity of Urine by Refractometry
250
1595
1.79
12.73
7.1
4.0
kg/l
1.0
1.0
1.07
33
224
(3019060) Gas panel - Arterial blood
93
419
2.36
12.41
4.9
5.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
139
737
2.05
12.39
10.6
7.5
kpa
4.8
5.1
3.08
133
710
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
53
180
3.07
12.30
1.6
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
33
82
4.14
12.20
3.1
3.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
603
4922
1.71
12.07
6.4
4.4
e6/l
163.3
1203.4
—
9
65
(3000570) Elastase.pancreatic [Mass/mass] in Stool
60
221
2.84
12.06
1.5
1.4
ug/g
292.6
306.9
0.21
32
122
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
12
10.98
11.98
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
13
12
10.98
11.98
1.0
1.1
%
100.4
104.4
0.17
13
12
(3048689) Calprotectin [Mass/mass] in Stool
166
951
1.92
11.83
1.8
2.1
ug/g
193.8
129.7
1.00
136
742
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
344
2444
1.67
11.68
4.9
3.0
u/l
30.9
31.8
0.21
331
2321
(4306422)
35
94
3.84
11.66
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
38
109
3.60
11.52
1.4
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
215
1346
1.79
11.52
3.9
2.4
mosm/kgh2o
496.8
528.5
1.64
199
1150
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
64
4.49
11.51
1.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
64
4.49
11.51
1.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
64
4.49
11.51
1.3
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
171
3.04
11.47
1.1
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
117
599
2.10
11.42
3.8
3.6
mmol/l
1.2
1.2
0.70
108
518
(3003396) Base excess in Arterial blood by calculation
136
740
1.99
11.24
10.8
7.4
mmol/l
0.9
1.3
0.59
107
587
(3020779) Urea [Moles/volume] in Serum or Plasma
104
515
2.16
11.05
9.5
6.7
mmol/l
9.0
8.9
0.03
97
492
(3044889) 12 lead EKG panel
633
5291
1.70
11.01
5.6
3.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
50
4.91
11.01
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
104
3.57
10.81
1.2
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
327
2329
1.64
10.79
3.0
2.3
u/l
58.8
56.5
0.52
297
2135
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
124
3.33
10.79
1.5
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
23
47
5.00
10.78
1.7
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
43
140
3.18
10.72
1.2
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
17
26
6.65
10.66
1.2
1.3
—
—
—
0
0
(44806118)
29
73
4.07
10.55
2.3
1.4
—
—
—
0
0
(44790049)
29
73
4.07
10.55
2.3
1.4
—
—
—
0
0
(44790047)
29
73
4.07
10.55
2.3
1.4
—
—
—
0
0
(44790048)
29
73
4.07
10.55
2.3
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
25
56
4.57
10.54
1.7
1.3
e6/l
2519.7
1734.2
0.31
15
36
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
85
398
2.26
10.36
5.9
3.3
kpa
5.2
5.2
0.25
80
374
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
21
41
5.22
10.35
1.7
1.5
u/l
10.4
5.7
0.38
14
19
(3012095) Magnesium [Moles/volume] in Serum or Plasma
183
1125
1.79
10.32
5.1
3.1
mmol/l
0.8
0.8
0.51
167
1055
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
15
8.78
10.25
1.2
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
251
1691
1.68
10.18
1.7
1.5
nmol/l
21.9
21.9
0.00
218
1427
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
10
11.13
10.18
1.2
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
354
2601
1.60
10.13
3.1
3.4
mmol/l
2.3
2.4
1.23
309
2290
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
63
262
2.51
10.00
2.1
1.9
ug/l
1.2
2.2
0.44
55
237
(3019309) Folate [Moles/volume] in Red Blood Cells
201
1281
1.74
9.97
1.8
1.7
nmol/l
1171.5
1217.7
0.30
159
945
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
28
6.17
9.95
1.1
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
28
6.17
9.95
1.1
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
28
6.17
9.95
1.1
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
13
9.34
9.89
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
12
13
9.34
9.89
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
26
65
4.09
9.56
1.8
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
49
184
2.76
9.53
3.3
2.6
g/l
3.5
3.7
0.33
49
179
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
139
804
1.87
9.50
2.6
2.5
umol/l
5.8
7.1
0.57
126
692
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
392
2986
1.56
9.41
2.1
1.9
pmol/l
95.7
96.8
0.16
196
1463
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
27
71
3.89
9.28
1.3
1.2
u/l
49.2
55.9
0.47
22
51
(3008152) Bicarbonate [Moles/volume] in Arterial blood
83
404
2.16
9.20
7.6
8.0
mmol/l
24.2
24.5
0.35
75
383
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
71
324
2.30
9.20
16.1
10.9
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
206
2.62
9.13
2.3
3.7
mg/l
68.3
77.9
0.09
45
162
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
12
9.27
8.99
3.3
7.8
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
22
51
4.40
8.90
1.7
1.3
e6/l
5909.2
176288.0
0.69
11
27
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
39
4.96
8.87
1.3
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
39
4.96
8.87
1.3
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
39
4.96
8.87
1.3
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
39
4.96
8.87
1.3
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
259
1817
1.60
8.73
5.9
3.5
%
91.9
93.7
0.60
248
1767
(3015235) Bicarbonate [Moles/volume] in Capillary blood
43
158
2.81
8.72
5.2
2.8
mmol/l
24.7
25.5
0.55
37
137
(3012441) Differential panel - Pleural fluid
22
52
4.31
8.70
1.7
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
78
380
2.15
8.63
5.8
3.2
mmol/l
1.8
1.9
0.16
58
296
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
206
2.57
8.62
2.3
3.7
mg/l
27.3
41.4
0.45
43
162
(3009343) pH of Capillary blood
80
394
2.13
8.61
6.0
3.3
ph
7.4
7.4
0.11
16
51
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
100
3.28
8.56
2.2
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
106
3.20
8.45
1.2
1.3
u/ml
332.7
260.3
0.67
20
63
(3042631) Mycobacterium sp identified in Specimen
30
91
3.38
8.41
2.2
2.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
26
72
3.69
8.33
1.8
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
78
3.54
8.14
2.7
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
110
620
1.88
8.11
6.4
3.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
11
9.18
8.10
2.7
8.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
116
3.01
7.89
1.2
1.3
—
—
—
0
0
(3036489) Thrombin time
57
254
2.33
7.82
3.1
2.2
s
22.0
21.1
0.31
48
226
(3000475) Leukocytes [#/volume] in Synovial fluid
41
157
2.69
7.72
1.7
1.7
e6/l
4101.4
13444.1
1.48
34
113
(3045424) Erythrocytes [Presence] in Urine
32
107
3.07
7.68
1.4
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
102
3.11
7.65
1.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
41
158
2.67
7.63
1.1
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
58
264
2.28
7.58
2.4
1.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
15
7.41
7.56
1.5
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
47
195
2.49
7.54
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
31
103
3.08
7.53
1.5
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
45
4.29
7.50
2.9
3.0
%
47.2
42.0
—
9
12
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
33
4.92
7.43
1.6
1.4
%
1.4
7.0
—
5
8
(3042733) HLA Ab [Presence] in Serum
12
9
13.50
7.40
4.4
1.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
22
59
3.80
7.39
1.7
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
506
4201
1.48
7.39
7.1
4.4
mmol/l
6.4
6.6
1.43
487
3922
(3005322) IgE [Units/volume] in Serum or Plasma
91
497
1.93
7.38
1.4
1.2
u/ml
79.6
220.1
2.01
84
454
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
45
185
2.51
7.36
1.7
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
553
4683
1.49
7.23
3.1
3.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
163
1064
1.65
7.21
3.5
2.6
e6/l
3.0
3.4
0.20
94
547
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
34
4.77
7.18
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
138
869
1.70
6.99
1.3
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
87
3.17
6.91
1.1
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
313
2388
1.48
6.88
3.6
3.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
44
4.16
6.84
2.1
2.1
e6/l
1234.1
662.4
—
9
16
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
233
1674
1.53
6.83
2.1
1.7
mg/l
1.5
1.0
0.81
189
1288
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
53
243
2.26
6.83
2.0
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
66
335
2.05
6.59
15.4
8.7
mmol/l
24.1
24.4
0.40
55
314
(3000991) Gas panel - Venous blood
92
528
1.83
6.41
14.0
7.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
92
530
1.82
6.33
2.5
2.4
au/ml
45.4
26.1
—
5
29
(3010144) Erythrocytes [#/volume] in Synovial fluid
21
61
3.50
6.32
1.6
1.5
e6/l
2103.7
119852.3
0.56
15
40
(3009871) Measles virus Ab [Titer] in Serum
12
22
5.52
6.30
1.5
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
33
127
2.66
6.19
4.0
2.3
%
13.9
16.1
1.65
22
63
(36660697) Celiac disease serology panel - Serum
102
613
1.75
6.09
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
44
197
2.30
6.02
1.2
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
18
49
3.73
5.94
2.1
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
84
480
1.83
5.94
1.4
1.3
au/ml
49.5
35.2
—
5
30
(3021788) Differential panel - Synovial fluid
32
125
2.62
5.85
1.7
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
70
3.20
5.77
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
681
6127
1.49
5.71
4.7
4.3
pmol/l
15.2
14.7
5.90
631
5605
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
212
1545
1.49
5.69
1.6
1.7
pmol/l
34091370.2
25450719.6
0.09
176
1277
(3045414) Leukocytes [Presence] in Urine
61
319
1.98
5.64
2.0
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
134
2.52
5.59
2.6
2.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
35
150
2.39
5.30
2.0
4.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
95
587
1.69
5.15
2.9
2.4
ml/min/173m2
65.9
66.6
0.06
44
238
(3022313) Gas panel - Capillary blood
56
295
1.96
5.09
5.2
3.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
17
50
3.45
5.04
1.5
1.4
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
11
23
4.83
5.02
1.5
1.5
umol/l
1.7
2.1
0.58
11
23
(3021901) Oxygen saturation in Capillary blood
28
112
2.55
4.92
6.0
2.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
33
3.98
4.72
1.2
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
95
602
1.65
4.69
4.2
3.2
mmol/l
1.8
1.9
0.15
74
480
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
67
385
1.80
4.69
1.7
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
103
2.57
4.66
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
140
2.33
4.66
1.5
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
30
128
2.39
4.62
4.9
3.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
76
2.81
4.47
3.3
3.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
92
586
1.64
4.45
3.7
3.4
ng/l
79.2
79.9
0.03
76
512
(3019225) pH of Specimen
110
733
1.57
4.42
4.7
3.9
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
12
7.56
4.36
1.3
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
191
2.09
4.35
3.3
3.1
u/ml
0.4
0.4
0.02
23
106
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
54
298
1.87
4.31
4.9
3.1
mmol/l
23.8
24.2
0.34
44
270
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
61
2.99
4.30
2.7
2.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
56
3.08
4.26
1.2
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
571
1.62
4.19
2.5
2.4
ug/l
17.2
6.2
0.57
72
504
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
34
162
2.14
4.08
1.3
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
43
224
1.97
4.08
3.0
3.0
g/l
0.4
0.2
0.45
19
82
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
67
402
1.72
4.07
1.6
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
760
7122
1.49
4.01
5.8
5.1
mu/l
2.1
2.1
0.01
710
6541
(3017817) Protein [Mass] in Urine collected for unspecified duration
16
53
3.06
3.98
1.8
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
59
2.92
3.91
1.1
1.2
—
—
—
0
0
(3010421) pH of Blood
34
165
2.10
3.91
5.3
3.2
ph
7.4
7.4
0.82
28
129
(3052851) Hemolysis interference index of Serum or Plasma
40
207
1.98
3.88
3.0
3.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
18
66
2.76
3.77
1.2
2.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
61
2.82
3.70
2.1
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
62
375
1.70
3.68
1.1
1.1
titre
—
131.8
—
0
9
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
16
5.67
3.66
1.9
2.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
45
3.15
3.66
2.3
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
28
130
2.19
3.61
5.9
3.5
mmol/l
2.4
3.0
0.61
23
89
(3003327) Ova and parasites identified in Stool by Light microscopy
45
249
1.85
3.60
1.9
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
46
3.08
3.54
2.3
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
13
6.20
3.50
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
222
2739
0.75
3.47
2.4
2.8
—
—
—
0
0
(3013512) EKG study
265
2165
1.32
3.42
5.5
3.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
76
2.53
3.39
3.7
3.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
14
5.76
3.34
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
115
2.21
3.31
1.5
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
96
2.32
3.29
1.1
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
27
130
2.11
3.21
4.3
2.8
umol/l
35.8
33.0
0.19
21
110
(3020891) Body temperature
46
269
1.75
3.11
5.7
4.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
464
0.48
3.11
2.4
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
50
2.83
3.09
2.3
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
8
7.54
3.06
1.3
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
8
7.54
3.06
3.3
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
8
7.54
3.06
1.0
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
178
1394
1.35
3.04
2.6
2.8
mmol/l
2.5
2.5
0.34
156
1247
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
674
0.57
3.02
1.5
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
96
678
1.47
2.98
2.4
2.2
u/l
31.4
36.9
0.90
86
567
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
69
2.49
2.97
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
468
0.50
2.95
1.3
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
17
4.74
2.92
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
101
724
1.45
2.91
4.6
3.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
66
433
1.57
2.89
1.5
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
13
5.42
2.87
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
23
3.94
2.78
2.3
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
31
3.25
2.78
1.1
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
31
3.25
2.78
1.1
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
10
31
3.25
2.78
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
66
2.45
2.72
1.1
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
54
343
1.61
2.72
3.2
2.5
e6/l
0.1
0.2
0.04
54
330
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
398
3504
1.25
2.69
5.3
3.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
68
2.38
2.57
2.3
2.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
44
2.75
2.55
1.3
1.1
—
—
—
0
0
(4010399)
80
563
1.46
2.55
1.7
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
11
5.48
2.54
2.0
8.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
46
715
0.62
2.54
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
26
136
1.94
2.52
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
26
136
1.94
2.52
1.4
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
16
4.40
2.48
3.3
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
216
1796
1.27
2.34
3.0
2.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
753
7185
1.33
2.34
22.0
11.9
ml/min/173m2
81.0
81.1
0.04
695
5879
(3045142) Bone marrow Pathology biopsy report
16
73
2.21
2.22
1.3
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
22
114
1.95
2.22
1.5
1.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
10
36
2.80
2.20
1.7
1.3
umol/l
25.6
30.5
—
10
36
(3051611) Lipemic interference index of Serum or Plasma
15
67
2.26
2.18
2.7
2.9
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
14
4.31
2.15
2.7
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
30
3.02
2.15
1.6
3.7
u/ml
1095.3
1424.3
—
9
30
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
68
2.23
2.12
1.3
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
95
2.02
2.12
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
95
2.02
2.12
1.4
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
25
3.22
2.10
3.6
5.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
62
2.28
2.08
1.8
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
96
2.00
2.06
1.4
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
28
162
1.75
2.04
1.2
1.5
e6/l
2.4
11.7
1.27
21
123
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
28
162
1.75
2.04
1.3
1.6
e6/l
473.8
570.1
0.07
22
129
(3047189) Immunofixation for 24 hour Urine
8
26
3.10
2.01
1.3
2.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
97
1.98
2.01
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
97
1.98
2.01
1.4
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
21
3.35
1.97
2.7
2.9
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
11
4.56
1.94
1.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
211
1.64
1.94
1.3
1.3
miu/ml
217.1
234.7
0.11
16
100
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
27
2.98
1.94
1.3
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
158
0.38
1.90
1.3
1.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
34
2.66
1.87
1.2
2.0
%
102.3
127.8
—
9
34
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
34
2.66
1.87
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
34
2.66
1.87
5.1
2.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
34
2.66
1.87
1.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
66
2.14
1.82
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
35
2.59
1.80
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
270
2361
1.21
1.80
3.2
2.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
799
7742
1.34
1.80
24.0
14.6
mmol/l
139.3
139.7
4.06
789
7545
(3017569) Oxygen content in Arterial blood
8
30
2.68
1.72
2.1
4.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
24
2.93
1.72
3.4
4.3
%
53.6
52.8
—
7
24
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
96
1.89
1.71
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
60
814
0.72
1.71
1.6
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
48
2.31
1.71
1.7
2.0
—
—
—
0
0
(4035726)
88
679
1.33
1.70
1.5
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
31
2.59
1.66
1.1
1.3
nmol/l
109.1
152.0
—
8
31
(4094501)
31
197
1.59
1.64
1.2
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
131
0.38
1.63
1.2
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
33
215
1.56
1.59
2.2
2.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
20
3.01
1.58
1.3
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
20
3.01
1.58
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
100
1.82
1.54
1.1
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
51
2.17
1.51
1.4
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
104
839
1.27
1.47
26.6
22.3
inr
1.0
1.2
3.41
16
111
(3023103) Potassium [Moles/volume] in Serum or Plasma
798
7763
1.30
1.47
24.2
14.7
mmol/l
3.9
3.9
0.79
787
7551
(4015189)
5
16
3.14
1.44
1.4
4.0
—
—
—
0
0
(1002224) Polysomnography panel
20
326
0.60
1.43
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
353
3212
1.17
1.43
2.3
2.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
276
0.57
1.42
1.6
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
97
1.77
1.35
1.4
1.2
nmol/l
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
75
1.88
1.35
2.3
1.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
44
2.06
1.27
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
15
85
1.78
1.23
3.1
2.2
pg
32.9
31.8
0.34
15
85
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
39
280
1.41
1.22
2.1
3.0
u/ml
24.2
927.5
1.01
31
246
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
111
924
1.23
1.22
9.0
6.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
19
2.64
1.21
2.4
2.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
37
2.17
1.21
1.4
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
31
214
1.46
1.19
5.9
3.6
mmol/l
3.9
3.8
0.49
31
197
(3051651) Icteric interference index of Serum or Plasma
8
39
2.06
1.15
2.1
3.2
—
—
—
0
0
(4027681)
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
150
1.55
1.15
1.3
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
104
1.65
1.10
1.2
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
43
321
1.36
1.10
3.5
2.3
%
1.1
1.2
0.49
43
321
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
41
1.96
1.09
3.6
3.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
802
7848
1.24
1.08
22.9
12.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
10
52
1.93
1.06
1.2
1.2
—
1.2
—
0
7
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
188
1.45
1.02
1.6
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
47
1.92
1.02
1.0
1.3
mmol/l
2.5
2.1
—
9
47
(3024263) Appearance of Synovial fluid
7
35
2.01
1.00
2.0
1.7
—
—
—
0
0
(4034850)
34
249
1.38
0.99
8.5
9.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
49
1.85
0.98
1.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
23
2.18
0.98
2.8
2.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
37
1.90
0.94
2.1
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
146
0.54
0.93
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
146
0.54
0.93
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
146
0.54
0.93
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
146
0.54
0.93
1.1
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
171
0.58
0.92
1.5
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
17
110
1.56
0.91
2.3
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
105
0.47
0.89
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
187
1.40
0.86
1.2
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
72
1.68
0.85
1.0
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
146
1.45
0.83
3.9
2.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
60
491
1.24
0.82
3.7
2.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
206
1.37
0.82
1.5
2.0
u/l
2214.2
3282.7
—
9
83
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
178
1602
1.14
0.82
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
845
8346
1.30
0.82
40.9
19.2
e9/l
261.6
258.1
0.83
840
8140
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
189
1.39
0.81
1.1
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
13
81
1.61
0.81
15.7
6.7
mg/l
12.8
12.2
0.15
13
75
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
247
0.68
0.80
1.2
1.5
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
2.4
—
2.5
—
0
10
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
33
1.82
0.79
1.0
2.4
—
—
—
0
0
(3004451) EKG impression Narrative
6
33
1.82
0.79
1.7
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.1
—
26.9
—
0
19
(3026361) Erythrocytes [#/volume] in Blood
845
8349
1.30
0.78
40.9
19.2
e12/l
4.4
4.4
6.57
839
8121
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
234
1.34
0.78
1.4
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
82
1.59
0.78
1.1
1.0
u/ml
0.3
3.5
—
6
27
(3010813) Leukocytes [#/volume] in Blood
845
8350
1.29
0.77
40.9
19.2
e9/l
6.6
6.6
0.28
839
8121
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
100
0.50
0.77
1.0
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
517
4952
1.11
0.77
4.2
3.0
u/l
56.4
46.4
1.86
486
4627
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.2
—
67.0
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
152
1363
1.14
0.74
1.7
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
39
308
1.28
0.73
1.4
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
31
237
1.32
0.73
1.4
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
25
2.01
0.72
1.2
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
110
0.54
0.72
2.0
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
683
6999
0.89
0.71
5.1
5.5
mmol/mol
38.5
39.4
1.01
638
6492
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
57
681
0.83
0.70
1.8
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
210
1930
1.12
0.69
1.4
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
61
1.65
0.68
1.4
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
64
541
1.20
0.67
1.3
1.6
—
—
—
0
0
(4146454)
11
70
1.58
0.65
3.6
2.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
233
1.30
0.65
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
31
242
1.29
0.65
1.3
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
79
1.53
0.63
1.1
1.0
u/ml
1.1
6.3
—
6
25
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
42
343
1.24
0.62
1.6
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
113
1.42
0.61
1.2
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
50
1.61
0.61
1.0
1.7
ug/l
6.6
8.3
—
8
41
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
300
1.24
0.59
1.5
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
60
512
1.18
0.58
1.8
3.1
pmol/l
4.2
4.5
2.31
49
452
(3035933) Granulocytes/100 leukocytes in Blood
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
213
1.28
0.54
1.4
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
60
1.51
0.54
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
60
1.51
0.54
1.1
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
38
1.58
0.54
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
38
1.58
0.54
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
96
0.62
0.52
1.3
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
47
399
1.19
0.50
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
45
1.56
0.49
1.6
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
46
1.53
0.48
2.0
6.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
173
1.28
0.47
2.9
2.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
31
255
1.22
0.46
2.1
2.2
nmol/l
12.9
12.7
0.02
25
225
(3000764) Benzodiazepines [Presence] in Urine
15
198
0.75
0.45
1.1
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
51
1.38
0.44
1.1
1.4
—
63.6
—
0
5
(3023323) Follitropin [Units/volume] in Serum or Plasma
35
414
0.84
0.43
1.5
1.3
iu/l
33.4
31.6
0.10
28
349
(3039443) Prostate specific Ag panel - Serum or Plasma
10
70
1.43
0.42
1.4
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
123
1.31
0.40
1.1
1.1
u/ml
0.5
1.8
—
9
49
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
88
1.37
0.40
1.3
1.4
pmol/l
239.3
314.3
—
7
69
(3008898) HLA-B27 [Presence]
22
269
0.81
0.38
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
216
2050
1.07
0.37
1.5
1.6
mmol/l
1.3
1.4
0.72
175
1734
(3035637) Corticotropin [Mass/volume] in Plasma
11
81
1.36
0.36
1.2
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
41
358
1.15
0.34
1.9
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
54
604
0.89
0.34
1.7
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
45
1.34
0.34
1.3
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
199
0.80
0.33
1.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
199
0.80
0.33
1.1
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
87
0.69
0.33
2.0
2.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
88
0.68
0.33
2.0
2.5
mmol/l
106.0
105.3
—
6
88
(3041354) Potassium [Moles/volume] in Venous blood
6
88
0.68
0.33
2.0
2.5
mmol/l
3.9
4.0
—
6
88
(3027944) Amphetamines [Presence] in Urine
16
198
0.80
0.32
1.1
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
74
1.36
0.32
2.4
1.8
pmol/l
159.4
202.7
—
10
69
(3002523) Influenza virus A Ag [Presence] in Specimen
15
119
1.27
0.32
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
399
1.13
0.31
1.6
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
85
783
1.09
0.31
2.4
4.0
ug/l
4.4
29.8
1.58
66
617
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
103
960
1.08
0.29
4.0
4.4
%
34.3
32.9
0.67
75
627
(3016879) Cocaine [Presence] in Urine
15
184
0.81
0.29
1.1
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
103
963
1.08
0.28
1.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
693
6843
1.06
0.28
29.0
14.1
%
39.1
39.4
0.46
454
4945
(21494434) Karyotype in Bone marrow
8
64
1.25
0.27
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
65
1.23
0.27
1.3
1.7
ug/l
12.1
18.8
—
8
65
(3000330) Specific gravity of Urine by Test strip
42
376
1.12
0.27
4.1
3.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
113
1.24
0.26
1.4
1.1
—
12.8
—
0
10
(3021387) Prolactin [Units/volume] in Serum or Plasma
27
234
1.16
0.26
1.7
1.6
mu/l
370.5
296.5
0.65
22
209
(4024509)
8
67
1.20
0.26
2.1
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
77
1.30
0.26
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
77
1.30
0.26
1.3
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
32
283
1.14
0.25
1.7
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
168
0.83
0.23
2.2
2.3
ug/min
31.1
84.8
—
6
99
(40758292) HTLV I+II Ab panel - Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.8
—
20.6
—
0
11
(3029396) Erythrocyte agglutination [Presence] in Blood
0
12
0.00
0.21
0.0
3.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
43
1.16
0.21
1.0
1.1
u/l
132.0
510.6
—
5
37
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
48
1.25
0.20
1.5
1.9
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
215
2220
0.96
0.20
4.1
3.8
mg/mmol
20.7
7.1
1.18
134
1314
(3023511) Choriogonadotropin [Units/volume] in Urine
9
114
0.79
0.20
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
50
1.20
0.19
2.0
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
128
1.17
0.18
1.1
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
153
0.85
0.18
3.8
3.8
mg/l
28.7
22.1
—
7
95
(3003740) Influenza virus B Ag [Presence] in Specimen
14
119
1.18
0.17
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
110
1.18
0.17
1.2
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
82
1.22
0.17
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
194
0.87
0.17
4.6
4.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
70
1.14
0.16
1.1
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
77
733
1.06
0.15
3.8
4.1
%
21.1
21.9
0.20
33
336
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
129
0.85
0.14
1.2
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
765
7692
0.96
0.14
4.7
4.9
mmol/l
2.6
2.8
7.68
716
7094
(3013139) Helicobacter pylori Ag [Presence] in Stool
56
530
1.06
0.13
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
106
0.85
0.13
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
123
1.14
0.12
1.2
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
105
1.14
0.11
1.0
1.0
u/ml
1.3
0.8
—
6
44
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
106
1.13
0.10
1.3
1.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
5
45
1.11
0.10
1.0
1.0
ng/l
57.4
51.6
—
5
27
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
5
45
1.11
0.10
1.0
1.0
ng/l
1115.0
672.5
—
5
26
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
45
1.11
0.10
1.0
1.0
ng/l
422.2
352.0
—
5
27
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
47
1.06
0.09
1.4
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
749
7516
0.98
0.07
4.3
4.4
mmol/l
1.6
1.5
2.76
699
6920
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
723
7257
0.98
0.07
3.9
3.9
mmol/l
1.2
1.3
4.88
676
6633
(3028707) Methadone [Presence] in Urine by Screen method
8
91
0.88
0.06
1.0
1.4
—
—
—
0
0
(4281824)
9
105
0.86
0.06
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
152
0.92
0.06
1.1
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
60
584
1.03
0.05
1.1
1.2
iu/ml
80.6
146.5
1.32
15
243
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
110
1.09
0.05
1.0
1.0
u/ml
0.9
3.1
—
7
55
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
95
936
1.02
0.03
4.6
4.4
ug/l
2.4
2.3
0.06
84
831
(3012516) Albumin [Mass/volume] in Urine
209
2107
0.99
0.03
3.4
3.1
mg/l
1360.8
305.0
0.98
130
1238
(3009508) Creatinine [Moles/volume] in Urine
220
2212
0.99
0.02
3.3
3.0
mmol/l
6.4
6.9
1.21
187
1872
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
739
7380
1.01
0.01
4.3
4.5
mmol/l
5.6
5.9
10.33
685
6721
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
67
678
0.99
0.01
1.7
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
15
148
1.01
0.00
5.5
1.6
nmol/l
0.8
0.8
0.17
15
121
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
79
786
1.01
0.00
1.3
1.7
%
1.5
1.4
0.94
62
693
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
163
0.98
0.00
1.7
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
54
539
1.00
0.00
2.8
2.8
ug/l
0.6
0.7
0.51
30
332
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
755
7549
1.00
0.00
4.3
4.4
mmol/l
4.6
4.8
5.17
708
6989
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
53.0
—
0
9
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
74
0.95
0.00
1.1
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44813793)
5
59
0.85
0.00
1.2
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
5
58
0.86
0.00
1.4
1.2
nmol/l
365.0
391.8
—
5
50
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
50
1.00
0.00
1.0
1.1
—
6.8
—
0
13
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
82
0.98
0.00
1.4
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
69
0.87
0.00
1.2
1.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_SYSTSLCE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_SYSTSLCE | 2.306 [2.03, 2.62] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.224 |
During the follow-up period (1.1.1998 — 31.12.2019), 615 out of 2768 females with M13_SYSTSLCE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_SYSTSLCE | 2.516 [2.0, 3.17] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.068 |
During the follow-up period (1.1.1998 — 31.12.2019), 197 out of 642 males with M13_SYSTSLCE died.
Mortality risk
Mortality risk for people of age
years, who have M13_SYSTSLCE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.252% | 0.559% |
| 5 | 1.311% | 3.123% |
| 10 | 3.181% | 8.172% |
| 15 | 6.414% | 15.352% |
| 20 | 11.51% | 24.944% |
Relationships between endpoints
↥Index endpoint: M13_SYSTSLCE – Systemic sclerosis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data